1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
blankLoading...

Pneumococcal vaccine

Pneumococcal vaccine

  • Pneumococcal vaccine is a mixture of capsular polysaccharides from 23 of the 83 most prevalent types of Streptococcus pneumoniae seen in the United States.
  • Pneumococcal vaccine is recommended for the following immunocompetent persons:
    • Persons 65 or more years of age. If an individual received vaccine more than 5 years earlier and was under age 65 at the time of administration, revaccination should be given.
    • Persons aged 2 to 64 years with chronic illness.
    • Persons aged 2 to 64 years with functional or anatomic asplenia. When splenectomy is planned, pneumococcal vaccine should be given at least 2 weeks prior to surgery.
    • Persons aged 2 to 64 years living in environments where the risk of invasive pneumococcal disease or its complications is increased. This does not include daycare center employees and children.
  • Pneumococcal vaccination is recommended for immunocompromised persons 2 years of age or older withHIV infection
    • leukemia, lymphoma, Hodgkin's disease, or multiple myeloma
    • generalized malignancy
    • chronic renal failure of nephritic syndrome and patients receiving
    • immunosuppressive therapy
    • organ or bone marrow transplant
  • A single revaccination should be given if 5 or more years have passed since the first dose in persons older than 10 years. In those who are 10 years or younger, revaccination should be given 3 years after the previous dose.
  • Because children less than 2 years of age do not respond adequately to the pneumococcal polysaccharide vaccine, a heptavalent pneumococcal conjugate vaccine was created that can be administered at 2, 4, and 6 months of age and between 12 and 15 months of age.

Pneumococcal vaccine

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments